Fortrea (NASDAQ: FTRE - Get Free Report) and MindWalk (NASDAQ: HYFT - Get Free Report) are both smal

Ausbil Investment Management Ltd trimmed its position in Fortrea Holdings Inc. (NASDAQ: FTRE) by 25.

Fortrea Holdings Inc. (NASDAQ: FTRE - Get Free Report) reached a new 52-week high during trading on

U.S. stocks rose; Apogee surged 10% on strong results and raised guidance, while Option Care, Ginkgo

Barclays analyst Luke Sergott upgrades Fortrea Holdings (NASDAQ:FTRE) from Equal-Weight to Overwe

DURHAM, N.C., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading gl

Fortrea Holdings Inc. (NASDAQ: FTRE - Get Free Report) has received a consensus rating of "Hold" fro

UBS analyst Kevin Caliendo initiates coverage on Fortrea Holdings (NASDAQ:FTRE) with a Neutral ra

Fortrea (NASDAQ: FTRE - Get Free Report) and Bullfrog AI (NASDAQ: BFRG - Get Free Report) are both s

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading g

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract r

David Smith, a current director on the Board, had acted as Interim Chief Financial Officer and princ

Fortrea (NASDAQ:FTRE) signed a definitive agreement to acquire the Early Phase Services division of

Fortrea acquires Worldwide Clinical Trials' Early Phase division for $45 million in cash to expa

Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide

Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea's early clinical developm

Fortrea Holdings Inc. is rated Buy at ~$18.86, driven by an earnings turnaround from aggressive cost

TD Cowen analyst Charles Rhyee maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises the

Citigroup analyst Brendan Digan maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises th

Fortrea Holdings Inc. (FTRE) might move higher on growing optimism about its earnings prospects, whi

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Ho

FTRE, ASML and KLAC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 31, 2026.

Fortrea Holdings Inc. (FTRE) could be a great choice for investors looking to buy stocks that have g

Truist Securities analyst Jailendra Singh maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and

Evercore ISI Group analyst Elizabeth Anderson maintains Fortrea Holdings (NASDAQ:FTRE) with a Out

Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and ra

Fortrea Holdings Inc. (FTRE) Q2 2026 Earnings Call Transcript

Fortrea NASDAQ: FTRE reported second-quarter 2026 revenue of $678.2 million and adjusted EBITDA of $

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.23 per share, beating the Zacks

Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.23 per share which beat the analyst

Fortrea Holdings (NASDAQ:FTRE) raises FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.

Four consecutive quarters of execution to drive commercial, operational and financial excellence Inc

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigati

Mizuho analyst Ann Hynes maintains Fortrea Holdings (NASDAQ:FTRE) with a Neutral and raises the p

2026 Financial GuidanceThe Company reiterates its guidance for the full year 2026, targeting revenue

Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO)

Top Wall Street analysts changed their outlook on top names. See all analyst rating changes, includi

Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and ra

Mizuho analyst Ann Hynes maintains Fortrea Holdings (NASDAQ:FTRE) with a Neutral and raises the p

Citigroup analyst Patrick Donnelly maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises

Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and ra

Fortrea Holdings (NASDAQ:FTRE) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2

Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.16 per share which beat the analyst

Evercore ISI Group analyst Elizabeth Anderson maintains Fortrea Holdings (NASDAQ:FTRE) with a Out

TD Cowen analyst Charles Rhyee upgrades Fortrea Holdings (NASDAQ:FTRE) from Hold to Buy and annou

Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and lo